ICR track cancer to ‘carbon date’ progression
May 11, 2017Research and Development Cancer, ICR, bowel cancer, oncology
The Institute of Cancer Research (ICR) has collaborated with sites across Scotland, Italy and the US to study the disease …
Scott Gottlieb appointed to the FDA’s top role
May 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, appointment
After months of scrutiny, Scott Gottlieb has been confirmed as the new Commissioner of the FDA, following his nomination by …
Think tank PHG Foundation urges UK government to deliver “transformational change” in NHS
May 11, 2017Medical Communications, Research and Development PHG Foundation, general election
Joining the wave of associations and organisations vocalising the needs of the health and life sciences industries in the run-up …
Body’s natural defence mechanism against TB discovered
May 11, 2017Research and Development Francis Crick Institute, TB, tuberculosis
Research conducted by the Francis Crick Institute has revealed how the body protects itself from Mycobacterium tuberculosis, the bacterium responsible …
HIV life expectancy boosted 10 years by new drugs
May 11, 2017Research and Development HIV
The latest research to emerge from authors of the University of Bristol has revealed that those living with HIV can …
The Spring 2017 edition of Pharmafile is available to read online now!
May 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, pharmafile
The Spring 2017 edition of Pharmafile, our bi-annual market intelligence report for the life sciences industry, is available to read …
Roche blockbuster immunotherapy Tecentriq outclassed by chemo in latest trial
May 10, 2017Research and Development, Sales and Marketing Roche, tecentriq
It has been revealed that Roche’s immuno-oncology drug Tecentriq (atezolizumab) has failed to hit its primary endpoint in a follow-up …
AZ asthma drug falls short in Phase 3 study
May 10, 2017Research and Development AstraZeneca, asthma, tralokinumab
AstraZeneca and its global biologics research and development arm MedImmune have announced that asthma treatment tralokinumab has failed to achieve …
Sanofi joins growing list of companies making pricing commitments
May 10, 2017Medical Communications, Research and Development Sanofi, pricing, transparency
Sanofi has entered an ever-growing list of pharmaceutical companies that are pledging to limit the levels of their price increases …
Study reveals EpiPens stay effective years after expiration date
May 10, 2017Research and Development EpiPen expiration, Mylan, Mylan scandal, epipen
The Annals of Internal Medicine has published a study that indicated that EpiPen injectors retain a medically significant proportion of …
Scott Gottlieb appointed to the FDA’s top role
May 10, 2017Manufacturing and Production, Research and Development, Sales and Marketing FDA, Scott Gottlieb, Trump
After months of scrutiny, Scott Gottlieb has been confirmed as the new Commissioner of the FDA, following his nomination by …
Kymab instates first Chief Medical Officer
May 9, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, kymab
Kymab, a therapeutic antibody company based in Cambridge, UK, has announced that it has appointed Dr Sonia Quaratino as its …
Duchenne drug poised to cost $35,000 but with major catch
May 9, 2017Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, PTC Therapeutics, marathon
For those that have not followed the story, Emflaza was successfully taken through the FDA regulatory process by Marathon as …
University of Oxford gains access to biomarker profiling technology
May 9, 2017Manufacturing and Production, Research and Development Nightingale health, University of Oxford
The University of Oxford has announced that it will benefit from Nightingale Health’s biomarker analysis technology. The Finnish company will …
73% of India’s doctors oppose prescribing generics over branded versions
May 9, 2017Manufacturing and Production, Sales and Marketing India, generics
Following a recent push by Indian Prime Minister Narendra Modi for doctors in the country to prescribe generic drugs over …
The Manufacturer’s Organisation calls for robust industrial strategy with new manifesto
May 9, 2017Manufacturing and Production EFF, The Manufacter's Organisaion
With the 8 June general election only a month away, the EEF – The Manufacturer’s Organisation – has become the …
£6 million statin study to determine potential therapeutic use in MS
May 9, 2017Manufacturing and Production, Research and Development multiple sclerosis, statins
A large study will take place in the UK to determine whether statins, commonly prescribed to combat “bad cholesterol”, are …
Pricing Consultant Job Profile and Description
May 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
About Global Pricing Innovations (GPI)
Head of Product Innovation Job Profile and Description
May 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
About Global Pricing Innovations (GPI)
Patient reported outcomes: Putting the patient first
May 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
With clinical practice marching towards a more precision-oriented methodology, assessment of treatment efficacy is undergoing a transformation. Matt Fellows explores the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
